Asian Journal of Research and Reports in Urology

Aim: As cutaneous metastasis of prostate cancer is very rare and there are very few documented cases in the literature, we want to present this case report.

Presentation of Case: A 62 years old patient presented to the outpatient department with complaints of continuous dribbling of urine and overflow incontinence with occasional painless gross haematuria for one month. He gave a history of enlarged inguinal lymph nodes. Investigations including blood biochemistry, urine analysis, ultrasonography and CECT abdomen were done followed by cystourethroscopy. Diagnostic biopsy from the left lateral wall of the bladder and a formal transurethral resection of the prostate was done and the specimen was sent for histopathological study.

Discussion: Prostate cancer, among other urological malignancy, is the third most common cause of skin metastasis. Cutaneous metastasis in prostatic cancer is rare and occurs in 0.09% of prostate adenocarcinoma. This increases with a relative increase in the elderly population and refractory or end-stage prostate cancer.

Conclusion: Cutaneous metastasis in prostate cancer carries a grave prognosis as in many other malignancies. Survival is generally between 6 weeks and 9 months. It is necessary for both the urologist as well as primary care physicians to be vigilant about these atypical observations in their daily practice.